RenovoRx Inc (RNXT) support and resistance · rev $266.0K
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
This page maps RenovoRx Inc (RNXT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
RNXT currently screens at market cap $47.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RNXT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RNXT quote page for the session range and the stock page for the full model.
Not investment advice.